| |
-Gabapentin (GABA)
-GAD Antibody
-GAD-65 Antibody
-Gamma Glutamyl Transferase, Serum (GGT)
-Gamma Glutamyl Transpeptidase
-Gamma GT
-Ganglioside Autoantibody Profile (GM1AB)
-Ganglioside Monosialic Acid Antibody
-Garamycin®
-Gastric Aspirate, pH
-Gastric Brush Rinse Cytology
-Gastric Brushing Smears
-Gastric Lavage Cytology
-Gastric Washing Cytology
-Gastrin (GTR)
-GBM Antibody
-GC Amplified DNA Probe
-GC by DNA Probe
-GC Culture
-GC Screen
-Genital Culture
-Genital Culture for Mycoplasma T-Strain
-Genital Culture for Neisseria Gonorrhoeae
-Genital Culture, Group B, Beta Strep Screen
-Genital Culture, Ureaplasma urealyticum
-Genital, Group B, Beta-Hemolytic Strep Screen, DNA (BSBP)
-Gentamicin Random (GENR)
-GentamicinPeak (GENP)
-GentamicinTrough (GENT)
-German Measles Screen
-German Measles Titer
-Gestational Diabetes Screen
-Gestational Glucose Tolerance Test
-Gestational Oral Glucose Tolerance Test
-GGT
-Giardia/Cryptosporidium Antigen Detection, Immunoassay (GIAG)
-Gliadin Antibodies
-Gliadin Autoantibody Profile (AGLP)
-Globulins, Urine
-Glomerular Basement Membrane Autoantibody (AGBM)
-Glomerular Basement Membrane Antibody
-Glucagon (GLUGB)
-Glucose 1-Hour Postprandial, Serum or Plasma (G1PP)
-Glucose 2-Hour Postprandial, Serum or Plasma (G2PP)
-Glucose Tolerance Test Oral 2 Hour (GTT2)
-Glucose Tolerance Test Oral 3 Hour (GTT3)
-Glucose Tolerance Test Oral, 5 Hour (GTT5 )
-Glucose Tolerance Test, Oral (Postpartum) (PPGT)
-Glucose Tolerance Test, Oral, (Gestational) (MGTT)
-Glucose, Amniotic Fluid (AGLU)
|
|
|
|
Print |
| Gabapentin |
| |
| CPT: |
80299 |
| |
| Alternate Name: |
Neurontin® |
| |
| Methodology: |
High Performance Liquid Chromatography (HPLC) |
| |
| Testing Schedule: |
Routine, 2 times per week |
| |
| Report Available: |
3-5 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL serum |
| |
| Container: |
Red top tube, no serum separator |
| |
| Collection: |
Therapeutic ranges are based on specimens drawn at trough (ie immediately before the next dose). |
| |
| Special Instructions and/or Comments: |
| Refrigerate |
| |
| Reference Range: |
| 2.0 - 20.0 mcg/mL |
| |
| Clinical Utility: |
| Useful for Monitoring serum concentration of gabapentin Assessing compliance, Assessing signs of toxicity. |
| |
Print |
| GAD Antibody |
| |
| See Glutamic Acid Decarboxylase Autoantibody |
Print |
| GAD-65 Antibody |
| |
| See Glutamic Acid Decarboxylase Autoantibody |
Print |
| Gamma Glutamyl Transferase, Serum |
| |
| CPT: |
82977 |
| |
| Alternate Name: |
Gamma Glutamyl Transpeptidase; Gamma GT; GGT; GT |
| |
| Methodology: |
HNL: Rate LPP: Bichromatic Rate |
| |
| Testing Schedule: |
Routine, STAT testing available |
| |
| Report Available: |
1 day |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL serum |
| |
| Container: |
Gold top (serum separator) tube |
| |
| Reference Range: |
| 8-78 units/L |
| |
| Clinical Utility: |
Used in the evaluation of hepatic, biliary and pancreatic disorders. |
| |
Print |
| Gamma Glutamyl Transpeptidase |
| |
| See Gamma Glutamyl Transferase,Serum |
Print |
| Gamma GT |
| |
| See Gamma Glutamyl Transferase, Serum |
Print |
| Ganglioside Autoantibody Profile |
| |
| Includes: |
•IgG Monosialo GM1 •IgM Monosialo GM1 •IgG Asialo GM1 •IgM Asisalo GM1 •IgG Disialo GD1b •IgM Disialo GD1b |
| |
| CPT: |
83520 x 6 |
| |
| Alternate Name: |
GM1 Antibody Profile Asialo GM-1 Antibody Disialo GM-1 Antibody Monosialo GM-1 Antibody |
| |
| Methodology: |
Enzyme-Linked Immunosorbent Assay (ELISA) |
| |
| Testing Schedule: |
Routine, 1 time per week |
| |
| Report Available: |
7-10 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
2 mL serum |
| |
| Container: |
Gold top (serum separator) tube |
| |
| Special Instructions and/or Comments: |
| Centrifuge, transfer to plastic aliquot tube and freeze.Once frozen, transport specimen submerged in dry ice. |
| |
| Reference Range: |
99% of normals fall at or below this titer | IgG Monosialo GM1 | 1:500 | | IgM Monosialo GM1 | 1:1,000 | | IgG Asialo GM1 | 1:4,000 | | IgM Asialo GM1 | 1:4,000 | | IgG Disialo GD1b | 1:1,000 | | IgM Disialo GD1b | 1:1,000 |
Clinical Utility Useful for, supporting diagnosis of neurological diseases primarily motor neuron disease and motor neuropathies |
| |
Print |
| Ganglioside Monosialic Acid Antibody |
| |
| See Ganglioside Autoantibody Profile |
Print |
| Garamycin® |
| |
| See Gentamicin |
Print |
| Gastric Aspirate, pH |
| |
| See pH, Body Fluid |
Print |
| Gastric Brushing Smears |
| |
| See Cytopathology, Direct Smears |
Print |
| Gastric Brush Rinse Cytology |
| |
| See Cytopathology, Fluid |
Print |
| Gastric Lavage Cytology |
| |
| See Cytopathology, Fluid |
Print |
| Gastric Washing Cytology |
| |
| See Cytopathology, Fluid |
Print |
| Gastrin |
| |
| CPT: |
82941 |
| |
| Alternate Name: |
Fasting gastrin |
| |
| Methodology: |
Automated Chemiluminescent Immunometric Assay |
| |
| Testing Schedule: |
Routine, daily |
| |
| Report Available: |
2-4 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL frozen serum |
| |
| Container: |
Gold top (serum separator) tube |
| |
| Collection: |
Patient must be fasting for at least 8 hours. |
| |
| Special Instructions and/or Comments: |
| •Centrifuge, transfer to plastic vial and freeze.Once frozen, transport specimen submerged in dry ice. |
| |
| Reference Range: |
| <100 pg/mL (>=8 hours fasting) |
| |
| Clinical Utility: |
| Useful for, investigation of patients with achlorhydria or pernicious anemi.Diagnosis of gastrinoma; basal and secretin-stimulated serum gastrin measurements are the best laboratory tests for gastrinoma. |
| |
Print |
| GBM Antibody |
| |
| See Glomerular Basement Membrane Autoantibody |
Print |
| GC Amplified DNA Probe |
| |
| See Neisseria Gonorrhoeae, Amplified DNA Probe |
Print |
| GC by DNA Probe |
| |
| See Neisseria Gonorrhoeae, Amplified DNA Probe |
Print |
| GC Culture |
| |
| See Culture, Neisseria Gonorrhoeae (GC Screen) |
Print |
| GC Screen |
| |
| See Culture, Neisseria Gonorrhoeae (GC Screen) |
Print |
| Genital Culture |
| |
| See Culture, Genital |
Print |
| Genital Culture for Mycoplasma T-Strain |
| |
| See Culture, Ureaplasma urealyticum |
Print |
| Genital Culture for Neisseria Gonorrhoeae |
| |
| See Culture, Neisseria Gonorrhoeae (GC Screen) |
Print |
| Genital Culture, Group B, Beta Strep Screen |
| |
| See Culture, Genital, Group B, Beta- Hemolytic Strep Screen |
Print |
| Genital Culture, Ureaplasma urealyticum |
| |
| See Culture, Ureaplasma urealyticum |
Print |
| GentamicinPeak |
| |
| CPT: |
80170 |
| |
| Alternate Name: |
Garamycin® |
| |
| Methodology: |
Immunoassay (IA) |
| |
| Testing Schedule: |
Routine, STAT testing available |
| |
| Report Available: |
1 day |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL serum |
| |
| Container: |
Red top or SST tube Adults •Trough collected immediately prior to next dose. •Random (Extended Interval Dosing)Collect 6-8 hours prior to next dose •Peak collected 60 minutes after an I.M. injection, 30 minutes after the end of a 30-minute I.V. infusion or immediately after a 60-minute I.V. infusion. •Neonates Collect 30 minutes post infusion. |
| |
| Special Instructions and/or Comments: |
Centrifuge, transfer serum to plastic aliquot tube and refrigerate or freeze.Once frozen, transport specimen submerged in dry ice. NOTE If a ß-lactam antibiotic is present sample must be frozen because of potential inactivation of aminoglycosides. |
| |
| Reference Range: |
Therapeutic •Peak 4.0-10.0 µg/mL •Trough1.0-2.0 µg/mL |
| |
| Critical Values: |
•Peak>12.0 µg/mL •Trough >2.0 µg/mL |
| |
| Clinical Utility: |
| Useful for monitoring blood concentrations during gentamicin therapy and assessing toxicity. |
| |
Print |
| Gentamicin Random |
| |
| CPT: |
80170 |
| |
| Alternate Name: |
Garamycin® |
| |
| Methodology: |
Immunoassay (IA) |
| |
| Testing Schedule: |
Routine, STAT testing available |
| |
| Report Available: |
1 day |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL serum |
| |
| Container: |
Red top or SST tube Adults •Trough collected immediately prior to next dose. •Random (Extended Interval Dosing)Collect 6-8 hours prior to next dose •Peak collected 60 minutes after an I.M. injection, 30 minutes after the end of a 30-minute I.V. infusion or immediately after a 60-minute I.V. infusion. •Neonates Collect 30 minutes post infusion. |
| |
| Special Instructions and/or Comments: |
Centrifuge, transfer serum to plastic aliquot tube and refrigerate or freeze.Once frozen, transport specimen submerged in dry ice. NOTE If a ß-lactam antibiotic is present sample must be frozen because of potential inactivation of aminoglycosides. |
| |
| Reference Range: |
Therapeutic •Peak 4.0-10.0 µg/mL •Trough 1.0-2.0 µg/mL |
| |
| Critical Values: |
•Peak>12.0 µg/mL •Trough >2.0 µg/mL |
| |
| Clinical Utility: |
| Useful for monitoring blood concentrations during gentamicin therapy and assessing toxicity. |
| |
Print |
| GentamicinTrough |
| |
| CPT: |
80170 |
| |
| Alternate Name: |
Garamycin® |
| |
| Methodology: |
Immunoassay (IA) |
| |
| Testing Schedule: |
Routine, STAT testing available |
| |
| Report Available: |
1 day |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL serum |
| |
| Container: |
Red top or SST tube •Adults •Trough collected immediately prior to next dose. •Random (Extended Interval Dosing)Collect 6-8 hours prior to next dose •Peak collected 60 minutes after an I.M. injection, 30 minutes after the end of a 30-minute I.V. infusion or immediately after a 60-minute I.V. infusion. •Neonates Collect 30 minutes post infusion. |
| |
| Special Instructions and/or Comments: |
Centrifuge, transfer serum to plastic aliquot tube and refrigerate or freeze.Once frozen, transport specimen submerged in dry ice. NOTE If a ß-lactam antibiotic is present sample must be frozen because of potential inactivation of aminoglycosides. |
| |
| Reference Range: |
Therapeutic •Peak 4.0-10.0 µg/mL •Trough 1.0-2.0 µg/mL |
| |
| Critical Values: |
•Peak >12.0 µg/mL •Trough >2.0 µg/mL |
| |
| Clinical Utility: |
| Useful for monitoring blood concentrations during gentamicin therapy and assessing toxicity. |
| |
Print |
| German Measles Screen |
| |
| See Rubella IgG Antibody, Immune Status |
Print |
| German Measles Titer |
| |
| See Rubella IgG Antibody, Immune Status |
Print |
| Gestational Diabetes Screen |
| |
| See Glucose, Gestational Diabetes Screen, Plasma |
Print |
| Gestational Glucose Tolerance Test |
| |
| See Glucose Tolerance Test, Oral (Gestational) |
Print |
| Gestational Oral Glucose Tolerance Test |
| |
| See Glucose Tolerance Test, Oral (Gestational) |
Print |
| GGT |
| |
| See Gamma Glutamyl Transferase, SerumGH |
| See Growth HormoneGiardia |
| See Giardia/Cryptosporidium Antigen Detection, Immunoassay |
Print |
| Giardia/Cryptosporidium Antigen Detection, Immunoassay |
| |
| Includes: |
Giardia and Cryptosporidium |
| |
| CPT: |
87328, 87329 |
| |
| Alternate Name: |
Cryptosporidium; Giardia |
| |
| Methodology: |
Enzyme Immunoassay (EIA) |
| |
| Testing Schedule: |
Routine, Monday-Friday |
| |
| Report Available: |
1-3 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
Fresh semi-formed OR liquid stool submitted in Para-Pak® containing 10% formalin, filled to red line.DO NOT use if fluid is yellow. |
| |
| Container: |
Parasitology collection kit |
| |
| Collection: |
•Following directions on pamphlet supplied with collection kit, pass stool into a clean, dry container. •Open tubes containing liquid and using spoon built into lid, place small scoopfuls of stool from bloody, mucous, or watery areas of specimen into tube until the contents rise to red line. •Mix and cap tightly. •Label containers. |
| |
| Reference Range: |
| No Giardia or Cryptosporidium by EIA. |
| |
| Clinical Utility: |
| Giardia and Cryptosporidium are pathogens found in stool and detecting their presence is important in patient management and infection control. |
| |
Print |
| Gliadin Antibodies |
| |
| See Gliadin Autoantibody Profile |
Print |
| Gliadin Autoantibody Profile |
| |
| Includes: |
IgG and IgA Autoantibodies to deamidated gliadin |
| |
| CPT: |
83516 (x2) |
| |
| Alternate Name: |
Anti-Gliadin Antibody Profile; Gliadin Antibodies |
| |
| Methodology: |
Enzyme Immunoassay (EIA) |
| |
| Testing Schedule: |
Routine, daily |
| |
| Report Available: |
3-5 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL serum |
| |
| Container: |
Gold top (serum separator) tube |
| |
| Special Instructions and/or Comments: |
| Refrigerate |
| |
| Reference Range: |
Gliadin IgG.........................<10.0 U/mL Gliadin IgA........................<5.0 U/mL |
| |
| Clinical Utility: |
| Useful for diagnosing celiac disease. IgG gliadin antibody (GA) testing approaches 100% sensitivity for Celiac disease (CD). |
| |
Print |
| Globulins, Urine |
| |
| See Protein Electrophoresis, Urine |
Print |
| Glomerular Basement Membrane Antibody |
| |
| See Glomerular Basement Membrane Autoantibody |
Print |
| Glomerular Basement Membrane Autoantibody |
| |
| CPT: |
83520 |
| |
| Methodology: |
Multiplex Flow Immunoassay |
| |
| Testing Schedule: |
Routine, daily |
| |
| Report Available: |
2-4 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL serum |
| |
| Container: |
Gold top (serum separator) tube |
| |
| Special Instructions and/or Comments: |
| Refrigerate |
| |
| Reference Range: |
•Negative................... <1U •Positive.................... > 1U |
| |
| Clinical Utility: |
| Evaluation of patients with rapid onset renal failure or pulmonary hemorrhage. |
| |
Print |
| Glucagon |
| |
| CPT: |
82943 |
| |
| Methodology: |
• Extraction • Radioimmunoassay |
| |
| Testing Schedule: |
Routine, 3 times per week |
| |
| Report Available: |
7-10 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
2 mL plasma |
| |
| Container: |
2 lavender top (EDTA) tube |
| |
| Collection: |
Overnight fast required. |
| |
| Special Instructions and/or Comments: |
| •Centrifuge tubes and transfer plasma to plastic aliquot vial. Transport at room temperature or refrigerated. |
| |
| Reference Range: |
| accompanies report |
| |
| Clinical Utility: |
| Glucagon measurement is useful primarily when considering a glucagon-secreting tumor of the pancreas. Glucagon is also used to diagnose gglucagon deficiency in patients with hypoglycemia. |
| |
Print |
| Glucose 1-Hour Postprandial, Serum or Plasma |
| |
| CPT: |
82947 |
| |
| Methodology: |
Endpoint |
| |
| Testing Schedule: |
Routine, STAT testing available |
| |
| Report Available: |
1 day |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL serum or plasma |
| |
| Container: |
Gold top (serum separator) tube OR gray top (sodium fluoride) tube |
| |
| Collection: |
Collect 1 hour post meal ingestion. |
| |
| Critical Values: |
| <40 OR >400 mg/dL |
| |
| Clinical Utility: |
Used in the evaluation of carbohydrate metabolism. |
| |
Print |
| Glucose 2-Hour Postprandial, Serum or Plasma |
| |
| CPT: |
82947 |
| |
| Methodology: |
Endpoint |
| |
| Testing Schedule: |
Routine, STAT testing available |
| |
| Report Available: |
1 day |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL serum or plasma |
| |
| Container: |
Gold top (serum separator) tube OR gray top (sodium fluoride) tube |
| |
| Collection: |
Collect 2 hours post meal ingestion. |
| |
| Reference Range: |
| > 10 years: <140mg/dL |
| |
| Critical Values: |
| <40 OR >400 mg/dL |
| |
| Clinical Utility: |
| Used in the evaluation of carbohydrate metabolism. |
| |
Print |
| Glucose-6-Phosphate Dehydrogenase |
| |
| CPT: |
82955 |
| |
| Alternate Name: |
G6PD |
| |
| Methodology: |
Kinetic Spectrophotometry |
| |
| Testing Schedule: |
Routine, daily |
| |
| Report Available: |
3-5 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
4 mL whole blood |
| |
| Container: |
Lavender top (EDTA) tube Special Note: ACD yellow top also acceptable |
| |
| Special Instructions and/or Comments: |
•Store as whole blood in original tube. •DO NOT centrifuge, aliquot or freeze. •Refrigerate only. |
| |
| Reference Range: |
| 8.6-18.6 IU/g Hb |
| |
| Clinical Utility: |
| Evaluation of individuals with Coombs-negative nonspherocytic hemolytic anemia. |
| |
Print |
| Glucose, Amniotic Fluid |
| |
| CPT: |
82945 |
| |
| Methodology: |
Endpoint |
| |
| Testing Schedule: |
Routine, STAT testing available |
| |
| Report Available: |
1 day |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL amniotic fluid |
| |
| Container: |
Amber transfer vial |
| |
| Reference Range: |
| None established, must be interpreted with clinical findings. |
| |
Print |
| Glucose, Body Fluid |
| |
| CPT: |
82945 |
| |
| Alternate Name: |
Body Fluid, Glucose, Glucose Pericardial; Glucose, Peritoneal; Glucose, Pleural; Glucose, Synovial Methodology Endpoint |
| |
| Testing Schedule: |
Routine, STAT testing available |
| |
| Report Available: |
1 day |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL body fluid |
| |
| Container: |
Red top tube, no serum separator |
| |
| Special Instructions and/or Comments: |
| Requisition Form must specify body fluid type. |
| |
| Reference Range: |
•Glucose, Fluid (other than synovial fluid); very similar to plasma glucose •Glucose, Synovial fluid; usually <10 mg/dL |
| |
Print |
| Glucose, Cerebrospinal Fluid |
| |
| CPT: |
82945 |
| |
| Alternate Name: |
Cerebrospinal Fluid Glucose; CSF Glucose |
| |
| Methodology: |
Endpoint |
| |
| Testing Schedule: |
Routine, STAT testing available |
| |
| Report Available: |
1 day |
| |
| Specimen Requirements: |
| Minimum Volume: |
0.5 mL cerebrospinal fluid |
| |
| Container: |
Sterile conical tube |
| |
| Collection: |
NOTE Tubes must be numbered indicating the sequence of collection. •Testing should be performed on tube #1. •Ideally, a blood glucose should be collected 2 hours prior to the lumbar puncture. |
| |
| Reference Range: |
40-85 mg/dL NOTE: Results should be interpreted with simultaneous blood glucose.Cerebrospinal fluid/blood glucose ratio should be 0.50-0.65. |
| |
| Critical Values: |
•<40 mg/dL •>400 mg/dL |
| |
| Clinical Utility: |
| Used to evaluate various diseases, disorders and trauma of the central nervous system. |
| |
Print |
| Glucose, Gestational Diabetes Screen, Plasma |
| |
| CPT: |
82950 |
| |
| Alternate Name: |
Gestational Diabetes Screen |
| |
| Methodology: |
HNL: Endpoint LPP: Biochromatic Rate |
| |
| Testing Schedule: |
Routine, STAT testing available |
| |
| Report Available: |
1 day |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL plasma |
| |
| Container: |
Gray top (sodium fluoride) tube |
| |
| Collection: |
•Administer the oral glucose solution (50 grams glucose load). •Patient must refrain from eating or drinking after ingesting the glucola and until the blood glucose sample is drawn 1 hour later. •The 1 hour time period begins when the patient starts to drink the glucola, which must be ingested within 5 to 10 minutes. •Collect specimen at 1 hour post oral glucose load. |
| |
| Special Instructions and/or Comments: |
| Test should be performed at 24-28 weeks gestation. |
| |
| Reference Range: |
| <135 mg/dL |
| |
| Critical Values: |
<40 mg/dL >400 mg/dL |
| |
| Clinical Utility: |
| Used in the evaluation of carbohydrate metabolism during pregnancy. |
| |
Print |
| Glucose, Pericardial |
| |
| See Glucose, Body Fluid |
Print |
| Glucose, Peritoneal |
| |
| See Glucose, Body Fluid |
Print |
| Glucose, Pleural |
| |
| See Glucose, Body Fluid |
Print |
| Glucose, Synovial |
| |
| See Glucose, Body Fluid |
Print |
| Glucose, Serum or Plasma |
| |
| CPT: |
82947 |
| |
| Alternate Name: |
Blood Sugar, Fasting or Non-fasting; Fasting Blood Glucose; Fasting Blood Sugar; FBS; Sugar, Fasting |
| |
| Methodology: |
HNL: Endpoint LPP: Bichromatic Rate |
| |
| Testing Schedule: |
Routine, STAT testing available |
| |
| Report Available: |
1 day |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL serum OR plasma |
| |
| Container: |
Gold top (serum separator) tube OR gray top (sodium fluoride) tube |
| |
| Collection: |
Overnight fast preferred |
| |
| Reference Range: |
Fasting: < 7 days: 47-110 mg/dL > 7 days: 65-99 mg/dL |
| |
| Critical Values: |
•<40 mg/dL •>400 mg/dL |
| |
| Clinical Utility: |
| Used in the evaluation of carbohydrate metabolism. |
| |
Print |
| Glucose Tolerance Test Oral 2 Hour |
| |
| CPT: |
82951 |
| |
| Testing Schedule: |
Routine, STAT testing available |
| |
| Report Available: |
1 day |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL plasma per collection |
| |
| Container: |
Gray top (sodium fluoride) tube |
| |
| Collection: |
• Overnight fast required. • A fingerstick glucose is performed by Point of Care testing. • If Point of Care glucose is >200 mg/dL, contact the laboratory to request the fasting glucose specimen submitted be performed STAT.If this result is >200 mg/dL, the physician is notified to determine if the test should continue. • If Point of Care glucose is <=200-mg/dL, administer 75 grams oral glucose solution and proceed with obtaining venous specimens at specified hourly intervals (not eating or drinking anything until the test is complete). |
| |
| Special Instructions and/or Comments: |
| For children and small adults, it is not advisable to administer 75 gram load.Administer 1.75 grams glucose/kg of body weight (1 kg = 2.2 lb).Contact a Customer Care Specialist at 610-402-8170 for further instructions. |
| |
| Reference Range: |
Fasting: < 7 days: 47-110 mg/dL > 7 days 65-99 mg/dL 2 Hour: > 10 years <140 mg/dL Diagnostic of Diabetes Fasting> 10 years >125 mg/dL 2 Hour> 10 years • Impaired glucose tolerance 140-199 mg/dL • Diabetes: >199 mg/dL |
| |
| Critical Values: |
•<40 mg/dL •>400 mg/dL |
| |
| Clinical Utility: |
Used in the evaluation of carbohydrate metabolism. |
| |
Print |
| Glucose Tolerance Test Oral 3 Hour |
| |
| CPT: |
82951, 82952 |
| |
| Methodology: |
Endpoint |
| |
| Testing Schedule: |
Routine, STAT testing available |
| |
| Report Available: |
1 day |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL plasma per collection |
| |
| Container: |
Gray top (sodium fluoride) tube |
| |
| Collection: |
• Overnight fast required. • A fingerstick glucose is performed by Point of Care testing. • If Point of Care glucose is >200 mg/dL, contact the laboratory to request the fasting glucose specimen submitted be performed STAT.If this result is >200 mg/dL, the physician is notified to determine if the test should continue. • If Point of Care glucose is <=200-mg/dL, administer 75 grams oral glucose solution and proceed with obtaining venous specimens at specified hourly intervals (not eating or drinking anything until the test is complete). |
| |
| Special Instructions and/or Comments: |
| For children and small adults, it is not advisable to administer 75 gram load.Administer 1.75 grams glucose/kg of body weight (1 kg = 2.2 lb).Contact a Customer Care Specialist at 610-402-8170 for further instructions. |
| |
| Reference Range: |
Fasting: < 7 days: 47-110 mg/dL > 7 days 65-99 mg/dL 2 Hour: > 10 years <140 mg/dL Diagnostic of Diabetes Fasting> 10 years >125 mg/dL 2 Hour> 10 years • Impaired glucose tolerance 140-199 mg/dL • Diabetes: >199 mg/dL |
| |
| Critical Values: |
•<40 mg/dL •>400 mg/dL |
| |
| Clinical Utility: |
| Used in the evaluation of carbohydrate metabolism. |
| |
Print |
| Glucose Tolerance Test Oral, 5 Hour |
| |
| Includes: |
•2-Hour Fasting, 1 and 2 hour specimens •3-Hour Fasting, 1, 2 and 3 hour specimens •5-Hour Fasting, 1, 2, 3, 4 and 5 hour specimens |
| |
| CPT: |
82951, 82952(X3) |
| |
| Methodology: |
Endpoint |
| |
| Testing Schedule: |
Routine, STAT testing available |
| |
| Report Available: |
1 day |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL plasma per collection |
| |
| Container: |
Gray top (sodium fluoride) tube |
| |
| Collection: |
•Overnight fast required. •A fingerstick glucose is performed by Point of Care testing. •If Point of Care glucose is >200 mg/dL, contact the laboratory to request the fasting glucose specimen submitted be performed STAT.If this result is >200 mg/dL, the physician is notified to determine if the test should continue. •If Point of Care glucose is <=200-mg/dL, administer 75 grams oral glucose solution and proceed with obtaining venous specimens at specified hourly intervals (not eating or drinking anything until the test is complete). |
| |
| Special Instructions and/or Comments: |
| For children and small adults, it is not advisable to administer 75 gram load.Administer 1.75 grams glucose/kg of body weight (1 kg = 2.2 lb).Contact a Customer Care Specialist at 610-402-8170 for further instructions. |
| |
| Reference Range: |
Fasting: < 7 days: 47-110 mg/dL > 7 days 65-99 mg/dL 2 Hour: > 10 years <140 mg/dL Diagnostic of Diabetes Fasting> 10 years >125 mg/dL 2 Hour> 10 years • Impaired glucose tolerance 140-199 mg/dL • Diabetes: >199 mg/dL |
| |
| Critical Values: |
•<40 mg/dL •>400 mg/dL |
| |
| Clinical Utility: |
| Used in the evaluation of carbohydrate metabolism. |
| |
Print |
| Glucose Tolerance Test, Oral, (Gestational) |
| |
| Includes: |
Fasting, 1, 2 and 3 hour specimens |
| |
| CPT: |
82951, 82952 |
| |
| Alternate Name: |
Gestational Glucose Tolerance Test; Gestational Oral Glucose Tolerance Test |
| |
| Methodology: |
Endpoint |
| |
| Testing Schedule: |
Routine, STAT testing available |
| |
| Report Available: |
1 day |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL plasma per collection |
| |
| Container: |
Gray top (sodium fluoride) tube |
| |
| Collection: |
• Overnight fast required. • A finger stick fasting glucose is performed by Point of Care testing. • If the fasting result is > 200 mg/dL, the physician is notified to determine if the test should continue. • If the result is <=200 mg/dL, administer 100 grams of oral glucose solution and proceed with obtaining venous specimen at 1 hour, 2 hours, and 3 hours (not eating or drinking anything until the test is complete). |
| |
| Special Instructions and/or Comments: |
| Patient should maintain an unrestricted diet for 3 days prior to the test which includes a fast for 8-14 hours prior to first collection. |
| |
| Reference Range: |
Fasting <95 mg/dL 1 hour <180 mg/dL 2 hours <155 mg/dL 3 hours <140 mg/dL |
| |
| Critical Values: |
<40 mg/dL >400 mg/dL |
| |
| Clinical Utility: |
| Used in the evaluation of carbohydrate metabolism. |
| |
Print |
| Glucose Tolerance Test, Oral (Postpartum) |
| |
| Includes: |
Fasting, 1 and 2 hour specimens |
| |
| CPT: |
82951 |
| |
| Methodology: |
Endpoint |
| |
| Testing Schedule: |
Routine, STAT testing available |
| |
| Report Available: |
1 day |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL plasma per collection |
| |
| Container: |
Gray top (sodium fluoride) tube |
| |
| Collection: |
•Overnight fast required. •A finger stick fasting glucose is performed by Point of Care testing. •If the fasting result is >200mg/dL, the physician is notified to determine if the test should continue. •If the results is <200mg/dL, administer 75 grams of oral glucose solution and proceed with obtaining venous specimen at 1 hour and 2 hours (not eating or drinking anything until the test is complete). |
| |
| Reference Range: |
•Fasting<=125 mg/dL •1-hour <200 mg/dL •2-hour <200 mg/dL |
| |
| Critical Values: |
•<40 mg/dL •>400 mg/dL |
| |
| Clinical Utility: |
| Used in the evaluation of carbohydratemetabolism. |
| |
Print |
| Glucose, Urine Random |
| |
| CPT: |
81050, 82945 |
| |
| Alternate Name: |
Sugar, Quantitative, Urine; Urinary Sugar Test |
| |
| Methodology: |
Endpoint |
| |
| Report Available: |
1 day |
| |
| Specimen Requirements: |
| Minimum Volume: |
5 mL random urine |
| |
| Container: |
Plastic urine container |
| |
| Collection: |
Random |
| |
| Special Instructions and/or Comments: |
| Transport to the laboratory promptly. |
| |
| Reference Range: |
| <30 mg/dL |
| |
| Clinical Utility: |
| Used to evaluate the presence of glycosuria;diabetes, renal and other disorders. |
| |
Print |
| Glucose, Urine 24-Hour |
| |
| Includes: |
•Volume Measurement •Collection Period •Creatinine, Urine •Glucose, Urine |
| |
| CPT: |
81050, 82945 |
| |
| Alternate Name: |
Sugar, Quantitative, Urine; Urinary Sugar Test |
| |
| Methodology: |
Endpoint |
| |
| Report Available: |
1 day |
| |
| Specimen Requirements: |
| Minimum Volume: |
Entire 24-Hour plastic urine collection |
| |
| Container: |
Entire 24-Hour plastic urine container, no preservatives |
| |
| Collection: |
24-Hour urine collection See special instructions for “24-Hour Urine Collection”, listed under Specimen Collection, |
| |
| Special Instructions and/or Comments: |
| Transport to the laboratory promptly. |
| |
| Reference Range: |
•Creatinine, 24-Hour Urine: 0.8-2.8 g/24 hours •Glucose, 24-Hour Urine: <0.5 g/24 hours |
| |
| Clinical Utility: |
| Used to evaluate the presence of glycosuria;diabetes, renal and other disorders. |
| |
Print |
| Glutamic Acid Decarboxylase Autoantibody |
| |
| CPT: |
86341 |
| |
| Alternate Name: |
Anti-GAD Antibody; GAD Antibody; GAD-65 Autoantibody |
| |
| Methodology: |
Radioimmunoassay |
| |
| Testing Schedule: |
Routine, Mon-Fri ONLY |
| |
| Report Available: |
5-7 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL serum |
| |
| Container: |
Gold top (serum separator) tube |
| |
| Special Instructions and/or Comments: |
| Refrigerate |
| |
| Reference Range: |
| < 0.02 nmol/L |
| |
| Clinical Utility: |
Useful for: • Assessing susceptibility to autoimmune (type 1, insulin-dependent) diabetes melitius and related endocrine disorders (eg, thyroiditis and pernicious anemia). Titers generally < 20 nmol/L. A second islet cell antibody, IA-2, is more predictive for development of type 1 diabetes, but less frequent than GAD65 Ab amongst diabetic patients. Insulin autoantibodies also serve as a marker of susceptibility to type 1 diabetes. • Distinguishing between patients with type 1 and type 2 diabetes. Assays for IA-2, insulin, gastric parietal cell, thyroglobulin, and thyroid peroxidase antibodies, complement GAD65 antibody in this context. Titers generally < 20 nmol/L • Confirming a diagnosis of stiff-man syndrome, autoimmune encephalitis, cerebellitis, brain stem encephalitis, myelitis. Titers generally > 20 nmol/L. • Confirming susceptibility to organ-specific neurological disorders (eg, myasthenia gravis, Lambert-Eaton syndrome). Titers generally < 20 nmol/L |
| |
Print |
| Glycosylated Hemoglobin |
| |
| See Hemoglobin A1c |
Print |
| Glycomark |
| |
| CPT: |
84378 |
| |
| Methodology: |
Enzymatic, Colorimetric Assay |
| |
| Testing Schedule: |
Routine, daily |
| |
| Report Available: |
3-5 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
1mL serum |
| |
| Container: |
Gold top (serum separator tube) |
| |
| Special Instructions and/or Comments: |
| Centrifuge tube and transfer serum to plastic aliquot vial. Refrigerate. |
| |
| Reference Range: |
• Males: 10.7 - 32.0 ug/mL • Females 6.8 - 29.3 ug/mL |
| |
| Clinical Utility: |
| Useful as a specific measure or after-meal-gluxose levels. GlycoMark provides a specific measure of average after-meal glucose levels over a period of one to two weeks with one single blood test. |
| |
Print |
| GM1 Autoantibody |
| |
| See Ganglioside Autoantibody Profile |
Print |
| Gonadotropin, Pituitary |
| |
| See Follicle Stimulating Hormone, Serum |
Print |
| Gonorrhea Culture |
| |
| See Culture, Neisseria Gonorrhoeae (GC Screen)GOT |
| See Aspartate Aminotransferase, Serum |
Print |
| GPT |
| |
| See Alanine Aminotransferase, Serum |
Print |
| Gram Stain |
| |
| Includes: |
Preparation, staining, and microscopic examination of the smear, including quantitative evaluation of relevant cells and microorganisms. |
| |
| CPT: |
87205 |
| |
| Alternate Name: |
Bacterial Smear; Direct Smear, Bacteria; Routine Stain, Bacteria |
| |
| Methodology: |
Gram stain |
| |
| Testing Schedule: |
Routine, STAT testing available |
| |
| Report Available: |
<=1 day; STAT 1 hour |
| |
| Specimen Requirements: |
| Minimum Volume: |
0.5 mL fluid, culture swab OR tissue in sterile container |
| |
| Collection: |
Collection procedure same as for routine culture of the specific site.Specimen must be collected to avoid contamination with skin, adjacent structures, and nonsterile surfaces. |
| |
| Special Instructions and/or Comments: |
Requisition Form must include site of specimen collection. |
| |
| Clinical Utility: |
| The gram stain is the mostimportant stain for bacteria and is an important diagnostic tool in subsequent identification procedures. |
| |
Print |
| Gross and Microscopic Pathology |
| |
| See Histopathology |
Print |
| Gross Worm Identification |
| |
| See Parasite Identification |
Print |
| Group A Beta-Hemolytic Streptococci Culture, Throat |
| |
| See Culture, Throat, Group A Beta- Hemolytic Streptococci Only |
Print |
| Group A Strep Antibody Screen |
| |
| See Streptolysin O Antibody |
Print |
| Group and Type |
| |
| See ABO and Rh (D) Type |
Print |
| Group B Strep Antigen, CSF |
| |
| See Bacterial Antigen Profile |
Print |
| Group B Strep Screen |
| |
| See Culture, Genital, Group B, Beta- Hemolytic Strep Screen |
Print |
| Growth Hormone |
| |
| Alternate Name: |
GH |
| |
| Methodology: |
Two site Immunoenzymatic Sandwich Assay |
| |
| Testing Schedule: |
Routine, daily |
| |
| Report Available: |
2-4 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL serum |
| |
| Container: |
Gold top (serum separator) tube |
| |
| Special Instructions and/or Comments: |
| Refrigerate |
| |
| Reference Range: |
Adults •Males....................0.01-0.97 ng/mL •Females.................0.01-3.61 ng/mL |
| |
| Clinical Utility: |
| Useful for, Diagnosis of acromegaly and assessment of treatment efficacy (in conjunction with glucose suppression test).Diagnosis of hGH deficiency (in conjunction with growth hormone stimulation test). |
| |
Print |
| GT |
| |
| See Gamma Glutamyl Transferase, Serum |
Print |
| Guaiac, Stool |
| |
| Replaced by Occult Blood, Stool |
Print |
| Genital, Group B, Beta-Hemolytic Strep Screen, DNA |
| |
| Includes: |
•Aerobic Culture •Identification of group B streptococci •Susceptibility testing if requested (additional CPT codes may apply) |
| |
| CPT: |
87081, Reflexed when appropriate See Billing Section for identification and susceptibility CPT codes page |
| |
| Alternate Name: |
• Beta-Hemolytic Strep Culture, Genital • Beta-Hemolytic Strep Group B Screen • Genital Culture, Group B, Beta Strep Screen • Group Strep B Screen |
| |
| Methodology: |
Standard reference procedures for aerobic bacterial culture and identification. |
| |
| Testing Schedule: |
Routine, daily |
| |
| Report Available: |
•Preliminary 1 day •Final with no growth after 2 days •Cultures with isolated pathogens minimum 2 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
Culture swab of vaginal AND anorectal area |
| |
| Collection: |
•Using a blue or red capped culture swab, first insert swab into the vagina then into the anorectum. •Return swab to transport tube, label. • DO NOT collect cervical specimen. |
| |
| Special Instructions and/or Comments: |
| Lab must be notified if patient is allergic to Penicillin |
| |
| Reference Range: |
| Negative for Beta Strep Group B |
| |
| Clinical Utility: |
| Group B Streptococcal disease is one of the most common infectious causes of neonatal morbidity and mortality. The CDC has proposed guidelines for the screening of all pregnant women for Group B Strep. |
| |
|